Christina Yap

University of Birmingham

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (17)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Sally Hopewell

University of Oxford

UNITED KINGDOM

View details

Haiyan Zheng

Senior Lecturer in Statistics

University of Bath

UNITED KINGDOM

View details

Johann S de Bono

Head of Clinical Studies Division

Institute of Cancer Research

UNITED KINGDOM

View details

Adrian Paul Mander

Professor of Medical Statistics

Cardiff University

UNITED KINGDOM

View details

Jerry Suls

Professor

Feinstein Institute for Medical Research

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Christina Yap

Research Interests

Explore related searches

Contact this professor

Articles (17)

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

U-PRO-CRM: designing patient-centred dose-finding trials with patient-reported outcomes

Exploring the barriers to, and importance of, participant diversity in early-phase clinical trials: an interview-based qualitative study of professionals and patient and public representatives

Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects

Reporting quality of CONSORT flow diagrams in published early phase dose-finding clinical trial reports: Improvement is needed

Ruxolitinib Versus Best Available Therapy for Polycythemia Vera Intolerant or Resistant to Hydroxycarbamide in a Randomized Trial

Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review

SPIRIT and CONSORT extensions for early phase dose-finding clinical trials: the DEFINE (DosE-FIndiNg Extensions) study protocol

Oncology phase I trial design and conduct: time for a change- MDICT Guidelines 2022

Enhancing quality and impact of early phase dose-finding clinical trial protocols: SPIRIT Dose-finding Extension (SPIRIT-DEFINE) guidance

Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance

Statistical methods and data visualisation of patient-reported outcomes in early phase dose-finding oncology trials: a methodological review

Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information

Subgroup analyses in randomized controlled trials frequently categorized continuous subgroup information

Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity

Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity

Practical guidance for running late-phase platform protocols for clinical trials: lessons from experienced UK clinical trials units

Collaborators (5)

Sally Hopewell

Haiyan Zheng

Johann S de Bono

Adrian Paul Mander

Jerry Suls

Make your next move.